Overview
Type: Vanderbilt Reinvestment Award (VRA)
By applying cutting-edge Vanderbilt technologies to the immune and genetic analysis of patients with immune diseases, this VRA will generate educational opportunities, discover new biology of immune regulation, and advance personalized immune medicine. The funds will be utilized to coordinate leading-edge trans-disciplinary research and accelerate Vanderbilt’s ability to generate paradigm-shifting fundamental discoveries of impact by leveraging knowledge of immunodeficiency states and genetic signatures and extending those findings to biomarker and drug discovery.
Faculty Participants
Lead Faculty in bold
SCHOOL OF MEDICINE (CLINICAL)
- Jeffrey Rathmell, Professor of Pathology, Microbiology and Immunology
- David Aronoff, Professor of Medicine
- Jim Connelly, Assistant Professor of Pediatrics
- Nancy Cox, Director, Vanderbilt Genetics Institute
- Leslie Crofford, Professor of Medicine
- Young Kim, Professor of Pathology, Microbiology and Immunology
- W. Rathmell, Cornelius Abernathy Craig Professor of Medicine
- Yu Shyr, Professor of Biostatistics
COLLEGE OF ARTS & SCIENCE
- Brian Bachmann, Professor of Chemistry
- John McLean, Stevenson Professor of Chemistry
SCHOOL OF MEDICINE (BASIC SCIENCE)
- Jonathan Irish, Assistant Professor of Cell and Developmental Biology